# Oral Treprostinil for the Treatment of Pulmonary Arterial Hypertension in Patients Receiving Background Endothelin Receptor Antagonist and Phosphodiesterase Type 5 Inhibitor Therapy (The FREEDOM-C2 Study)

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/oral-treprostinil-for-the-treatment-of-pulmonary-arterial-hypertension-in/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Victor F. Tapson,Zhi‐Cheng Jing,Kai‐Feng Xu,Lei Pan,Jeremy Feldman,David G. Kiely,Eugene Kotlyar,C. Shane McSwain,Kevin Laliberte,Carl Arneson,Lewis J. Rubin |
| Citations | 294 |
| DOI | 10.1378/chest.12-2875 |
| Fields | Medicine |
| Open Access | false |
| OA Status | closed |
| OpenAlex ID | https://openalex.org/W4241487982 |
| Type | article |
| Year | 2013 |

## Paper authors

- [Eugene Kotlyar](https://scholariq.org/researchers/eugene-kotlyar/)

## Paper journal

- [CHEST Journal](https://scholariq.org/journals/chest-journal/)

## Paper primary topic

- [Pulmonary Hypertension Research and Treatments](https://scholariq.org/topics/pulmonary-hypertension-research-and-treatments/)

## Paper topics

- [Pulmonary Hypertension Research and Treatments](https://scholariq.org/topics/pulmonary-hypertension-research-and-treatments/)
- [Cardiovascular Issues in Pregnancy](https://scholariq.org/topics/cardiovascular-issues-in-pregnancy/)
- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.